Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» DOJ
DOJ
Medtronic to halt manufacture of pain drug pump -U.S. regulators
Yahoo/Reuters
Mon, 04/27/15 - 09:29 pm
Medtronic
devices
DOJ
SynchroMed
pain drug pumps
Alleged patient safety kickbacks lead to $1 million settlement
Mass Device
Wed, 03/4/15 - 08:18 am
DOJ
kickbacks
devices
CareFusion
ChloraPrep
DOJ Enforcement Panel Focuses on Medical Device Companies
Policy and Medicine
Tue, 02/17/15 - 09:58 am
DOJ
devices
Justice Department Probes Generic Competition After Price Hike Reports
WSJ Pharmalot
Mon, 11/10/14 - 11:00 am
DOJ
generics
Impax Laboratories
Lannett
DOJ interested in Impax Labs paper trail
Seeking Alpha
Fri, 11/7/14 - 09:04 am
Impax Labs
DOJ
Ranbaxy Faces Medicaid Pricing Probe by the Justice Department
WSJ Pharmalot
Thu, 09/18/14 - 09:01 am
Ranbaxy
Medicaid
DOJ
U.S. clears AstraZeneca over heart drug trial
Yahoo/Reuters
Tue, 08/19/14 - 08:05 am
AstraZeneca
Brilinta
DOJ
Aegerion gets DOJ subpeona over marketing of cholesterol drug Juxtapid
Yahoo/Reuters
Fri, 01/10/14 - 08:23 am
DOJ
Juxtapid
Aegerion
DOJ wants info from AstraZeneca about heart drug study
Bizjournals.com
Thu, 10/31/13 - 10:15 am
DOJ
AstraZeneca
Brilinta
A Jilted Shire Exec, Age Discrimination And A Federal Probe?
Pharmalot
Thu, 05/30/13 - 11:28 am
Shire
age discrimination
DOJ
As Forest CEO Plans Retirement, The Feds Issue A New Subpoena
Pharmalot
Tue, 05/28/13 - 06:33 pm
Tudorza Pressair
Howard Solomon
Forest Labs
DOJ
DOJ Investigating Sanofi Over Plavix Disclosure
Motley Fool
Tue, 03/12/13 - 11:25 am
Sanofi
DOJ
Plavix
Bristol-Myers Squibb
Feds still zealous about off-label marketing, DoJ official says
Fierce Pharma
Wed, 02/13/13 - 11:08 am
whistleblowers
off-label
DOJ
The US Department of Justice's targeting of medical speech and its public health impacts
American Enterprise Institute
Wed, 12/12/12 - 10:06 am
DOJ
off-label
FTC, DOJ Propose to Adopt Rule Changes On Premerger Notification for Rx Companies
Bloomberg BNA
Thu, 08/16/12 - 01:03 pm
DOJ
FTC
M&A
J&J faces new marketing probes as Risperdal settlement nears
Fierce Pharma
Tue, 08/7/12 - 12:49 pm
JNJ
Risperdal
Doribax
DOJ
Relieva Stratus MicroFlow Spacer
J&J close to settling with DOJ over marketing-WSJ
Reuters
Thu, 06/21/12 - 07:36 am
JNJ
DOJ
Risperdal
Ranbaxy brings in U.S. consultants as part of consent decree
Fierce Pharma
Fri, 05/25/12 - 11:21 am
Ranbaxy
India
generics
United States
DOJ
Diabetes: DOJ investigates Shires' DermaGraft marketing
Thu, 04/26/12 - 10:20 pm
diabetes
DOJ
Dermagraft
market
DOJ Subpoena May Rattle Old Skeletons in Merck’s Closet
BNET Pharma
Wed, 08/10/11 - 10:50 am
hepatitis C
melanoma
cancer
Intron A
Temodar
DOJ
PegIntron
Merck
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
next ›
last »